Clinical Trial Update: Passive Safety Surveillance Data of Dengue Vaccine, Qdenga (TAK 003) in Private Vaccination Sites in Buenos Aires, Argentina.

View source ↗

Summary

This document reports an update on passive safety surveillance data for the dengue vaccine Qdenga (TAK-003) collected from private vaccination sites in Buenos A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Qdenga (TAK-003)

Snippet

Sponsor: Fundación Vacunar | Conditions: Dengue Vaccines | Status: ACTIVE_NOT_RECRUITING